PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Schulich School of Business, York University, Toronto, Ontario, Canada.\', \'Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.\', \'Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.\', \'Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA; Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA. Electronic address: shiyi.wang@yale.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00548-810.1016/j.ijid.2021.06.059
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34216734
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all